Pharmaceutical Policy Research & Analysis

The contract entails comprehensive research and analysis on pharmaceutical pricing structures, evolving market dynamics, and the effects of policy interventions to support the regulatory strategy and oversight functions of the Health Policy Commission. The work requires detailed examination of national and state-level trends in drug costs, manufacturer pricing behavior, payer responses, and legislative or regulatory changes influencing access and affordability, with findings directly informing HPC’s policy development and enforcement actions. The research must be rigorous, data-driven, and focused on identifying systemic issues and emerging risks within the pharmaceutical supply chain to guide evidence-based decision-making. This subcontract is issued by the Massachusetts-based Health Policy Commission under NAICS code 541611 for scientific research and development in the social sciences and humanities, with responses due by July 17, 2026. The performance location is not specified beyond the agency’s state affiliation, and no set-aside provisions apply. The contractor will be expected to deliver actionable insights through reports, briefings, or analytical tools that enhance the agency’s capacity to monitor market transparency, evaluate pricing fairness, and support policy initiatives aimed at controlling costs while ensuring patient access to essential medications.